# JPMorgan China Growth & Income plc (JCGI.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Financial Services. Price 262p, market value 206 millionp.

## Valuation
- **P/E (trailing): 7.9×** (5-yr avg 6860.9×, 3-yr avg 1764.3×). JPMorgan China Growth & Income plc trades at 7.9× trailing earnings, well below its own five-year average of 6860.9×: cheap by its own standards. The Financial Services median in the September 2026 study was 13.1×.
- **Price / sales: 4.1×**. Each dollar of revenue is priced at 4.1×.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 2.6×**. Enterprise value is 2.6× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 1.1%** (5-yr avg 0.0%). Free cash flow equals 1.1% of the market value, above its five-year average of 0.0%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 12.6%**. The inverse of the P/E: 12.6% of the price is earned each year.

## Profitability
- **Gross margin: 96.0%**. JPMorgan China Growth & Income plc keeps 96.0% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 154.2%**. 154.2% of revenue is left after running the business, an exceptional level.
- **Return on equity: 22.5%**. 22.5% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 27.6%**. Return on all capital, debt included, is 27.6%: comfortably above what that capital costs.
- **Return on assets: 25.9%**. Each dollar of assets produces 25.9% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): 131.4%** (5-yr -41.4%/yr). Revenue grew 131.4% over the last year, against -41.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 901.3%** (5-yr -19.7%/yr). Earnings per share rose 901.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.
- **Cash and short-term investments: 6 millionp**. Leverage ratios are shown differently for banks and insurers, whose balance sheets are built on deposits and reserves; use return on equity and the regulatory capital in the filings instead.

## Dividends
- **Dividend: none**. JPMorgan China Growth & Income plc does not currently pay a dividend, but it returned 1.4% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): -3.2%** (YTD -6.5%, 3-mo -3.6%). The shares are down 3.2% over twelve months including dividends.
- **From 52-week high: -20.3%** (0.7% above the low). Trading 20% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 0.32** (volatility 21%). Beta of 0.32 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=JCGI.L · Page: https://foliofundamentals.com/stocks/jcgi.l

Not investment advice.